Literature DB >> 17194741

Proteomic profiling of cold thyroid nodules.

Kerstin Krause1, Stefan Karger, Angelika Schierhorn, Sylvie Poncin, Marie-Christine Many, Dagmar Fuhrer.   

Abstract

Cold thyroid nodules (CTNs) represent a frequent endocrine disorder accounting for up to 85% of thyroid nodules in a population living in an iodine-deficient area. Benign CTNs need to be distinguished from thyroid cancer, which is relatively rare. The molecular etiology of benign CTNs is unresolved. To obtain novel insights into their pathogenesis, protein expression profiling was performed in a series of 27 solitary CTNs (10 follicular adenoma and 20 adenomatous nodules) and surrounding normal thyroid tissues using two-dimensional gel electrophoresis combined with mass spectrometry analysis, Western blotting, and immunohistochemistry. The proteome analysis revealed a specific fingerprint of CTNs with up-regulation of three functional systems: 1) thyroid cell proliferation, 2) turnover of thyroglobulin, and 3) H2O2 detoxification. Western blot analysis and immunohistochemistry confirmed the proteome data and showed that CTNs exhibit significant up-regulation of proteins involved in thyroid hormone synthesis yet are deficient in T4-containing thyroglobulin. This is consequential to intranodular iodide deficiency, mainly due to cytoplasmic sodium iodide symporter localization, and portrays the CTN as an activated proliferating lesion with an intranodular hypothyroid milieu. Furthermore, we provide preliminary evidence that up-regulation of H2O2 generation in CTNs could override the antioxidative system resulting in oxidative stress, which is suggested by the finding of raised 8-oxo-guanidine DNA adduct formation in CTNs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194741     DOI: 10.1210/en.2006-0752

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Proteomic analysis of human thyroid fine needle aspiration fluid.

Authors:  L Giusti; P Iacconi; F Ciregia; G Giannaccini; F Basolo; G Donatini; P Miccoli; A Lucacchini
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

2.  Quantitative proteomics: assessing the spectrum of in-gel protein detection methods.

Authors:  Victoria J Gauci; Elise P Wright; Jens R Coorssen
Journal:  J Chem Biol       Date:  2010-06-19

3.  Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.

Authors:  Kerstin Krause; Susanne Prawitt; Markus Eszlinger; Christian Ihling; Andrea Sinz; Katrin Schierle; Oliver Gimm; Henning Dralle; Frank Steinert; Sien-Yi Sheu; Kurt W Schmid; Dagmar Fuhrer
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

4.  Amyloid precursor protein as a potential marker of malignancy and prognosis in papillary thyroid carcinoma.

Authors:  Zhili Yang; Youben Fan; Zhaoxian Deng; Bo Wu; Qi Zheng
Journal:  Oncol Lett       Date:  2012-03-08       Impact factor: 2.967

5.  Proteomic profiling of follicular and papillary thyroid tumors.

Authors:  Anastasios Sofiadis; Susanne Becker; Ulf Hellman; Lina Hultin-Rosenberg; Andrii Dinets; Mykola Hulchiy; Jan Zedenius; Göran Wallin; Theodoros Foukakis; Anders Höög; Gert Auer; Janne Lehtiö; Catharina Larsson
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

6.  Differences in the Plasma Proteome of Patients with Hypothyroidism before and after Thyroid Hormone Replacement: A Proteomic Analysis.

Authors:  Assim A Alfadda; Hicham Benabdelkamel; Afshan Masood; Anwar A Jammah; Aishah A Ekhzaimy
Journal:  Int J Mol Sci       Date:  2018-01-01       Impact factor: 5.923

Review 7.  Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.

Authors:  Silvia Cantara; Carlotta Marzocchi; Tania Pilli; Sandro Cardinale; Raffaella Forleo; Maria Grazia Castagna; Furio Pacini
Journal:  Int J Mol Sci       Date:  2017-04-06       Impact factor: 5.923

8.  NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.

Authors:  Junguee Lee; Koon Soon Kim; Min Ho Lee; Yeon Soo Kim; Min Hee Lee; Seong Eun Lee; Yong Kyung Kim; Min Jeong Ryu; Soung Jung Kim; Min Jeong Choi; Young Suk Jo
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

9.  The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.

Authors:  Raymon H Grogan; Elliot J Mitmaker; Orlo H Clark
Journal:  Cancers (Basel)       Date:  2010-05-20       Impact factor: 6.639

10.  Protein Co-Expression Analysis as a Strategy to Complement a Standard Quantitative Proteomics Approach: Case of a Glioblastoma Multiforme Study.

Authors:  Evangelos I Kanonidis; Marcia M Roy; Ruth F Deighton; Thierry Le Bihan
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.